Lightning Round and Lens Therapeutics Approval

Rapid-fire stock calls from callers followed by a deep dive on Lens Therapeutics' FDA-approved VIZ eye drops, market opportunity, pricing, and adoption risks versus Vuity.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app